This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $25,449.26. The contract has an ultimate completion date of August 29, 2024. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award, valued at $1,746.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a completion date of February 5, 2025. The contract is a delivery order, with a firm fixed-price pricing type. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,098.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565393817 OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of August 9, 2024 and is not a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a $26,609.42 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of 4,565,698,957 units of the prescription medication OLUMIANT 2 MG TABLET 30S. The delivery order has a firm fixed price structure and a completion date of September 6, 2024. This contract is not set aside for any specific business type. Amerisourcebergen has been awarded...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 4564042960 OLUMIANT 2 MG TABLET 30S. The order, valued at $1,940.78, has a performance period through March 22, 2024. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation and serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
This federal contract award, valued at $4,062.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a medical product, with a period of performance through February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,903.02, is a Firm Fixed Price Delivery Order for the supply of OLUMIANT 2 MG TABLET 30S. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,633.37 firm fixed-price delivery order is for OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The award is a firm fixed price delivery order for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,940.78 and a performance period through February 13, 2024. No set-aside designations were used for this contract. Amerisourcebergen Drug Corp holds...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, the prime contractor, a firm fixed price delivery order contract valued at $3,549.10 to provide OLUMIANT 2 MG TABLET 30S to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...